首页 | 本学科首页   官方微博 | 高级检索  
     

ER PR及Her-2在乳腺癌中的表达及预后分析
引用本文:吕金梅. ER PR及Her-2在乳腺癌中的表达及预后分析[J]. 长治医学院学报, 2010, 24(4)
作者姓名:吕金梅
作者单位:阳泉市第一人民医院,045000
摘    要:目的:探讨雌激素受体(ER)、孕激素受体(PR)及Her-2蛋白在乳腺浸润性导管癌中的表达及预后分析.方法:应用免疫组化SP法检测66例乳腺浸润性导管癌ER、PR、Her-2的表达.结果:ER的阳性表达与肿瘤的TNM分期和淋巴结转移呈负相关;PR的阳性表达与肿瘤的TNM分期和淋巴结转移无相关性;Her-2蛋白的阳性表达与肿瘤的TNM分期和淋巴结转移及肿瘤的复发呈正相关.结论:ER、PR、Her-2联合免疫组化检测是判断乳腺癌预后的重要指标.

关 键 词:乳腺癌  激素受体  癌基因

Expression of ER,PR,Her-2 in Breast Cancer and Prognosis
Lü Jinmei. Expression of ER,PR,Her-2 in Breast Cancer and Prognosis[J]. Journal of Changzhi Medical College, 2010, 24(4)
Authors:Lü Jinmei
Abstract:Objective:To study the expression of estrogen receptor(ER),progestogen receptor(PR)and Her-2 in breast invasive ductal carcinoma(IDC) and prognosis.Methods: Expression of ER,PR Her-2 of 66 invasive ductal carcinoma patients were determined by immunohistochemical staining.Results: The expression of ER was negayively correlated with TNM stage and lymph nodes metastasis.The expression of PR was not correlated with TNM stage and lymph nodes metastasis.The expression of Her-2 was correlated with TNM stage and ly...
Keywords:Breast cancer  ER  Oncogene  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号